Navigation Links
January is National Glaucoma Awareness Month
Date:1/3/2008

30TH ANNIVERSARY GALA SET FOR JAN. 23, 2008

SAN FRANCISCO, Jan. 3 /PRNewswire/ -- In celebration of National Glaucoma Awareness Month, Glaucoma Research Foundation (GRF) will commemorate its 30th Anniversary with a gala benefit at the Westin St. Francis Hotel Tower in San Francisco, Jan. 23, 2008. The annual event, "Speeding the Cure. Spreading the Word." serves as the showcase for recent advances in GRF-funded research.

Glaucoma is the leading cause of preventable blindness. With an aging population, millions worldwide risk blindness from glaucoma if nothing is done. "Everyone is vulnerable to this silent thief of sight, but typically less than half are aware of the threat. Early detection and treatment is the only way to prevent further vision loss," says Thomas M. Brunner, GRF president and CEO. At highest risk are African Americans (where the disease strikes earlier and progresses more aggressively), Hispanics/Latinos, Asians, anyone over the age of 60, and everyone with a family history of glaucoma.

A national foundation established in 1978 in San Francisco by Dr. Robert M. Shaffer (1912-2007), Dr. H. Dunbar Hoskins Jr. and Dr. John Hetherington, GRF is the nation's leading funder of innovative glaucoma research, outside of government, academia and the corporate sector. GRF is the definitive source for glaucoma information, distributing educational print materials on request and serving 500,000 unique visitors each year at http://www.glaucoma.org.

The Gala begins at 5 p.m. with a scientific overview of recent research advances presented by the four principal investigators of GRF's Catalyst for a Cure consortium. A reception follows at 6 p.m. and dinner commences at 7 p.m.

Individual Gala tickets are $300, with tables available at $25,000, $15,000, $10,000 and $6,000. For information or to receive an invitation, please contact Craig Palmer, 415.986.3162 or <
'/>"/>

SOURCE Glaucoma Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
3. January 1 Looms Large for Lymphoma Patients
4. China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. The Long Term Care Insurance Explosion; January Conference to Celebrate Rapid Growth of LTC Protection and Light Fuse of Further Expansion
7. Datascope Adjourns Annual Meeting of Shareholders to January 3, 2008
8. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
9. Biodel Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 7th, 2008
10. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
11. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... have made a discovery that turns 160 years of ... material long known to be essential for the fast ... is not as ubiquitous as thought, according to a ... Harvard Stem Cell Institute (HSCI) and the University,s Department ... Professor Jeff Lichtman, of Harvard,s Department of Molecular and ...
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... of chronic inflammation in non-cancerous prostate tissue may have ... than those with no inflammation, according to results of ... Hopkins Kimmel Cancer Center. , The link between persistent ... so-called high-grade prostate cancer those with a Gleason ... of the most aggressive and rapidly growing prostate cancers. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2
... IRVING, Texas, Dec. 13 Allarae Healthcare,Inc. (Pink Sheets: ... with Intellect, Inc. to sell their entire product line ... broad range,of personal health testing kits, several already FDA ... kits are ready for market but have,not yet been ...
... as Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA ... the completion of a new network,infrastructure to support a ... and Thurrock University Hospitals, part,of the NHS Foundation Trust ...
... shouldn,t feel like,getting your teeth drilled, according to Mirabai ... industry. For anyone who,s vowed to,start exercising in the ... help them get going. Recently released on DVD, the ... exercise,going at their own pace, so they,re more likely ...
... and females in order to alleviate back pressure from ... spearheaded at The University of Texas at Austin. , ... in the Dec. 13 issue of Nature. , The ... million years ago, in the early human ancestor Australopithecus. ...
... to allowing us to see, the mammalian eye also detects ... of this is the timing of the sleep/wake cycle, which ... pacemaker in the hypothalamus. , In a study published ... two totally blind humans whose non-visual responses to light remain ...
... 13 PARI,s eFlow, an advanced,electronic nebulizer, was ... Phase I human clinical trial. Results of the ... Annual Drug Delivery to the Lungs meeting held,in ... developed as a,treatment for respiratory syncytial virus (RSV) ...
Cached Medicine News:Health News:Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc. 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2Health News:Adapting to pregnancy played key role in human evolution, study shows 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3Health News:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study 2
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle. Designated most popular model or size....
8 mm curved blade. Cutting edge on inside of curve. Flat handle....
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size....
Medicine Products: